Zaidon T. Al-Aqbi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zaidon T. Al-Aqbi has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Salim Albukhaty
University of Misan
5 shared publications- Ghassan Mohammad Sulaiman
Department of Biotechnology, College of Applied Sciences, University of Technology, Baghdad, Iraq
4 shared publications Abdulkarim Albishri
3 shared publications- Faris Abdulridha Jassim Al-Doghachi
Chemistry Department, Faculty of Science, University of Basrah, 61004, Basrah, Iraq
3 shared publications - Hassan T. Abdulsahib
Department of chemistry, Faculty of science, University of Basrah, Basrah, Iraq
3 shared publications - Salim Albukhaty
Department of pharmaceutical chemistry, College of Pharmacy, University of Manara, Maysan, Iraq
3 shared publications
Latest Publications
- 19 December 2025
- Published by Springer Nature in Ionics
- Vol. 32 (2) , 1825-1834
Sol-gel prepared nanostructured LiMPO4 (M = Ag, Cu and Al) cathode materials: synthesis, magnetic and electrochemical properties for lithium-ion batteries application
- 19 December 2025
- Published by Springer Nature in Ionics
- Vol. 32 (2) , 1825-1834
Sol-gel prepared nanostructured LiMPO4 (M = Ag, Cu and Al) cathode materials: synthesis, magnetic and electrochemical properties for lithium-ion batteries application
- 10 November 2025
- Published by Springer Nature in Microfluidics and Nanofluidics
- Vol. 29 (12) , 1-20
Nanosensors-based integrated microfluidic devices for therapeutic drug monitorIng of fentanyl citrate, tramadol, and pethidine in blood plasma
- 10 November 2025
- Published by Springer Nature in Microfluidics and Nanofluidics
- Vol. 29 (12) , 1-20
Nanosensors-based integrated microfluidic devices for therapeutic drug monitorIng of fentanyl citrate, tramadol, and pethidine in blood plasma
- Open Access
- 9 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (37) , 43309
Correction to “High-Efficiency Adsorption of Uranium from Wastewater Using Graphene Oxide/Graphene Oxide Nanoribbons/Chitosan Nanocomposite Aerogels”
[This corrects the article DOI: 10.1021/acsomega.4c01608.].
- 9 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (37) , 43309
Open AccessCorrection to “High-Efficiency Adsorption of Uranium from Wastewater Using Graphene Oxide/Graphene Oxide Nanoribbons/Chitosan Nanocomposite Aerogels”
[This corrects the article DOI: 10.1021/acsomega.4c01608.].
- 19 February 2025
- Published by Springer Nature in Chemical Papers
- Vol. 79 (4) , 2585-2601
Chalcone-based colorimetric naked eye detection of vanadium in crude oil using a new microfluidic device
- 19 February 2025
- Published by Springer Nature in Chemical Papers
- Vol. 79 (4) , 2585-2601
Chalcone-based colorimetric naked eye detection of vanadium in crude oil using a new microfluidic device
- Open Access
- 23 December 2024
- Published by Taylor & Francis in Green Chemistry Letters and Reviews
- Vol. 18 (1)
Green synthesis of silver nanoparticles using Trema Orientalis (L.) extract and evaluation of their antibacterial activity
- 23 December 2024
- Published by Taylor & Francis in Green Chemistry Letters and Reviews
- Vol. 18 (1)
Open AccessGreen synthesis of silver nanoparticles using Trema Orientalis (L.) extract and evaluation of their antibacterial activity
- Open Access
- 13 June 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (25) , 27260-27268
High-Efficiency Adsorption of Uranium from Wastewater Using Graphene Oxide/Graphene Oxide Nanoribbons/Chitosan Nanocomposite Aerogels
A chemical exfoliation and freeze-drying technique was used to create graphene oxide/graphene oxide nanoribbons/chitosan aerogels (GO/GONRs/CS). Aerogels were utilized to study uranium adsorption through batch experiments. Environmental influences on U(VI) adsorption were studied, including the starting concentration of U(VI), contact time, pH, and temperature. In order to characterize the composite, FTIR, SEM, XRD, and TEM analyses were used. A pseudo-second-order kinetic model may adequately represent the kinetics of U(VI) adsorption onto the surface of aerogels. The Freundlich model can explain the adsorption isotherm; the maximal adsorption capacity for U(VI) was determined to be 1208.85 mg/g; the adsorption process for U(VI) was endothermic, spontaneous, and pH-dependent; and the mechanism of adsorption is the chemisorption process. Chemisorption typically involves strong chemical interactions between the adsorbate (uranium ions) and the functional groups present on the surface of the adsorbent (the aerogel). Graphene oxide and graphene oxide nanoribbons contain oxygen-containing functional groups such as carboxyl (−COOH), hydroxyl (−OH), and epoxy (−O−) groups, which can act as active sites for chemical bonding. Chitosan, a polysaccharide derived from chitin, also possesses functional groups like amino (−NH2) and hydroxyl groups. Uranium ions, in their U(VI) form, can form chemical bonds with these functional groups through various mechanisms such as electrostatic interactions, complexation, and coordination bonds. The combination of graphene oxide-based materials and chitosan in the nanocomposite aerogel offers several advantages, including a large specific surface area, chemical stability, and the presence of functional groups for effective uranium adsorption.
- 13 June 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (25) , 27260-27268
Open AccessHigh-Efficiency Adsorption of Uranium from Wastewater Using Graphene Oxide/Graphene Oxide Nanoribbons/Chitosan Nanocomposite Aerogels
A chemical exfoliation and freeze-drying technique was used to create graphene oxide/graphene oxide nanoribbons/chitosan aerogels (GO/GONRs/CS). Aerogels were utilized to study uranium adsorption through batch experiments. Environmental influences on U(VI) adsorption were studied, including the starting concentration of U(VI), contact time, pH, and temperature. In order to characterize the composite, FTIR, SEM, XRD, and TEM analyses were used. A pseudo-second-order kinetic model may adequately represent the kinetics of U(VI) adsorption onto the surface of aerogels. The Freundlich model can explain the adsorption isotherm; the maximal adsorption capacity for U(VI) was determined to be 1208.85 mg/g; the adsorption process for U(VI) was endothermic, spontaneous, and pH-dependent; and the mechanism of adsorption is the chemisorption process. Chemisorption typically involves strong chemical interactions between the adsorbate (uranium ions) and the functional groups present on the surface of the adsorbent (the aerogel). Graphene oxide and graphene oxide nanoribbons contain oxygen-containing functional groups such as carboxyl (−COOH), hydroxyl (−OH), and epoxy (−O−) groups, which can act as active sites for chemical bonding. Chitosan, a polysaccharide derived from chitin, also possesses functional groups like amino (−NH2) and hydroxyl groups. Uranium ions, in their U(VI) form, can form chemical bonds with these functional groups through various mechanisms such as electrostatic interactions, complexation, and coordination bonds. The combination of graphene oxide-based materials and chitosan in the nanocomposite aerogel offers several advantages, including a large specific surface area, chemical stability, and the presence of functional groups for effective uranium adsorption.
- 1 June 2024
- Published by Elsevier in European Polymer Journal
- Vol. 214
Fabrication, characterization and application of biocompatible nanocomposites: A review
- 1 June 2024
- Published by Elsevier in European Polymer Journal
- Vol. 214
Fabrication, characterization and application of biocompatible nanocomposites: A review
- 11 March 2024
- Published by Springer Nature in Analytical Sciences
- Vol. 40 (6) , 1101-1110
Micro/nanofluidic device for tamsulosin therapeutic drug monitoring in patients with benign prostatic hyperplasia at point of care
Discovering the balance between toxicity and efficacy for many drugs requires therapeutic drug monitoring (TDM) of their concentrations in the blood. Here, a hot-embossed microfluidic device with a new design integrated to a nanofracture is presented for purification of blood samples from numerous proteins and cells, allowing to the separation of small molecules from blood matrix. The device was used to separate and quantitatively detect tamsulosin drug after derivatization with fluorescamine reagent, allowing converting it from a neutral molecule into a charged fluorescent complex under the experimental conditions, and thus its separation by electrophoresis. The device is portable and easy operated, and the presented method showed good linearity (R2 = 0.9948) over a concentration range of 0.1–1 μg/mL. The relative standard deviation (RSD%) was below 10% (n = 3), indicating good precisions, and the limit of detection (LOD) and limit of quantitation (LOQ) values were estimated to be 0.1 and 0.55 μg/mL, respectively. Whole blood samples from 10 patients with benign prostatic hyperplasia (BPH) were analyzed, showing good percentage recoveries of tamsulosin in whole blood. This point-of-care (POC), low-cost method could increase the convenience of patients and doctors, make therapies safer, and make TDM available in different regions and places. Graphical abstract
- 11 March 2024
- Published by Springer Nature in Analytical Sciences
- Vol. 40 (6) , 1101-1110
Micro/nanofluidic device for tamsulosin therapeutic drug monitoring in patients with benign prostatic hyperplasia at point of care
Discovering the balance between toxicity and efficacy for many drugs requires therapeutic drug monitoring (TDM) of their concentrations in the blood. Here, a hot-embossed microfluidic device with a new design integrated to a nanofracture is presented for purification of blood samples from numerous proteins and cells, allowing to the separation of small molecules from blood matrix. The device was used to separate and quantitatively detect tamsulosin drug after derivatization with fluorescamine reagent, allowing converting it from a neutral molecule into a charged fluorescent complex under the experimental conditions, and thus its separation by electrophoresis. The device is portable and easy operated, and the presented method showed good linearity (R2 = 0.9948) over a concentration range of 0.1–1 μg/mL. The relative standard deviation (RSD%) was below 10% (n = 3), indicating good precisions, and the limit of detection (LOD) and limit of quantitation (LOQ) values were estimated to be 0.1 and 0.55 μg/mL, respectively. Whole blood samples from 10 patients with benign prostatic hyperplasia (BPH) were analyzed, showing good percentage recoveries of tamsulosin in whole blood. This point-of-care (POC), low-cost method could increase the convenience of patients and doctors, make therapies safer, and make TDM available in different regions and places. Graphical abstract